rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Abel De La Rosa

Director

Company insider

Files Form 4 as: Director, Dogwood Therapeutics.

In numbers

Trades disclosed
10
Buys
1
Sells
0
Bought
$24K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
22 Jun 2021
Last trade
16 Jun 2026
Last filed
17 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
DWTX Dogwood TherapeuticsDirector · Biotechnology · last 16 Jun 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 17 Jun 2026DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,800 at $0.00filing
16 Jun 2026filed 17 Jun 2026DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,800 at $0.00filing
27 Jun 2025filed 1 Jul 2025DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—2,362 at $0.00filing
18 Jun 2025filed 23 Jun 2025DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—210 at $0.00filing
18 Jun 2025filed 23 Jun 2025DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—210 at $0.00filing
26 Feb 2024filed 28 Feb 2024DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—3,959 at $0.00filing
15 Jun 2023filed 20 Jun 2023DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,250 at $0.00filing
23 Jun 2022filed 30 Jun 2022DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—5,250 at $0.00filing
7 Jan 2022filed 7 Jan 2022DWTX Dogwood TherapeuticsBiotechnologySEC FORM 4 Bought$24K4,000 at $5.90filing
22 Jun 2021filed 23 Jun 2021DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,875 at $0.00filing

News

Dogwood Therapeutics, Inc (NASDAQ:DWTX) Sees Significant Drop in Short InterestDWTX · themarketsdaily.com · 14 Oct 2026

0 headlines in the last 90 days name Abel De La Rosa; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

John C. ThomasDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
Richard James WhitleyDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
David R. KeeferDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
Angela WalshChief Financial Officer · Chief Financial Officer at Dogwood Therapeutics, filing Form 4 there in the last year
Ralph GrosswaldSVP of Operations · SVP of Operations at Dogwood Therapeutics, filing Form 4 there in the last year